Improved Long-Term Health : Beyond autoimmune conditions, weight loss improves cardiovascular health, which is often a concern for these patients
Intriguingly, for secondary outcome analyses, oral semaglutide was strongly associated with all-cause and cardiovascular death reduction but not non-fatal events while dulaglutide and subcutaneous semaglutide mainly reduced non-fatal stroke but not mortality
3 Is sublingual bremelanotide FDA-approved
Muscle preservation, bone density maintenance, cardiovascular adaptation, and metabolic health all require attention during aggressive weight loss
Its also important to note that the effects of the weight loss shot, Wegovy, develop gradually, and it can take several weeks for the full effects to be felt